Orchidia Pharmaceutical Industries

Orchidia Pharmaceutical Industries is a leading pharmaceutical company specializing in the production of ophthalmic products. Ranked number two in the Egyptian ophthalmic market, Orchidia Pharmaceutical Industries demonstrates a commitment to growth and innovation within the industry. With a state-of-the-art manufacturing facility in Al-Obour city spanning 6,000 M², Orchidia Pharmaceutical Industries operates one of the largest facilities in the Middle East, boasting a current production capacity of 35 million units.

Orchidia Pharmaceutical Industries is certified with WHO-GMP implementation from the Egyptian MOH and other countries of registration in the Middle East and Africa, as well as ISO 9001, ISO 14001, and OHSAS certifications. The company maintains and continually improves its Quality Management Systems (QMS) and Environmental Health and Safety (EHS) standards, ensuring high-quality products that exceed stakeholder expectations. The primary address of Orchidia Pharmaceutical Industries is Industrial Zone, Area 15, Block no.12011, Obour city, EG.

With a portfolio that includes 35 ophthalmic drugs and 3 medical devices holding CE marked certificates, Orchidia Pharmaceutical Industries is dedicated to advancing eye care solutions. Furthermore, the company has a robust pipeline of 60 drugs in various ophthalmic forms. Orchidia Pharmaceutical Industries is strategically positioned for continued success and expansion. We invite the manager of Orchidia Pharmaceutical Industries to create a customized and exclusive company showcase and product listing on our platform.